Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Post by PUNJABIon Apr 09, 2021 8:56am
201 Views
Post# 32965431

FP says Canopy Growth, rivals are doing deals

FP says Canopy Growth, rivals are doing dealsCanopy Growth Corp (C:WEED)
Shares Issued 382,163,991
Last Close 4/8/2021 $35.75

Friday April 9 2021 - In the News

Also Aphria Inc (C:APHA) In the News
Also Organigram Holdings Inc (C:OGI) In the News
Also Zenabis Global Inc (C:ZENA) In the News

The Financial Post reports in its Friday edition that Canopy Growth is buying The Supreme Cannabis Co. in a $435-million cash-and-stock deal, which comes on the heels of its purchase of AV Cannabis last week. The Post's guest columnist Avery Mullen writes that Canopy chief executive officer David Klein says: "It allows us to create the really strong, home-market anchor point that we want for Canopy, which allows us to invest in our consumer more than anybody else and create products that excite our consumers. We're still sitting here with $2.5-billion of cash on our balance sheet. That cash will ultimately be used for investments in insight, innovation, brand building, and capital investments mostly focused in the U.S., and mergers and acquisitions mostly focused on the U.S." Canopy reported cash and short-term investments of about $1.59-billion in its latest quarterly earnings that ended Dec. 31, 2020. Elsewhere, Aphria and Tilray are about to merge, and Hexo is set to acquire Zenabis Global. As well, a British American Tobacco unit recently acquired a 19.9-per-cent interest in Organigram Holdings. Canadian pot players are eyeing the U.S. market, which is valued at $35-billion (U.S.) by 2025.

<< Previous
Bullboard Posts
Next >>